These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 776473)

  • 1. The complement system in bullous pemphigoid. IV. Chemotactic activity in blister fluid.
    Diaz-Perez JL; Jordon RE
    Clin Immunol Immunopathol; 1976 May; 5(3):360-70. PubMed ID: 776473
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemotactic activity in the fluid of bullous pemphigoid blisters].
    Diáz Pérez JL; Jordon RE
    Med Cutan Ibero Lat Am; 1975; 3(6):465-70. PubMed ID: 778510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement in pemphigus vulgaris and other bullous dermatoses.
    Sbano E; Auteri A; Fimiani M; Volpi L
    Arch Dermatol Res (1975); 1975 Dec; 254(2):143-8. PubMed ID: 56159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and blister fluid anticomplementary activity in pemphigus and bullous pemphigoid. Sucrose density gradient studies.
    Jordon RE; McDuffie FC
    Proc Soc Exp Biol Med; 1976 Mar; 151(3):594-8. PubMed ID: 768993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An eosinophil chemotactic factor present in blister fluids of bullous pemphigoid patients.
    Baba T; Sonozaki H; Seki K; Uchiyama M; Ikesawa Y; Toriisu M
    J Immunol; 1976 Jan; 116(1):112-6. PubMed ID: 1107422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
    Jordon RE; Nordby JM; Milstein H
    J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.
    Gammon WR; Inman AO; Wheeler CE
    J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile bullous pemphigoid.
    Skeete M; Greaves MW
    Br J Dermatol; 1976 Jul; 95 Suppl 14():23-5. PubMed ID: 776201
    [No Abstract]   [Full Text] [Related]  

  • 9. Deposition of the membrane attack complex of complement in bullous pemphigoid.
    Dahl MV; Falk RJ; Carpenter R; Michael AF
    J Invest Dermatol; 1984 Feb; 82(2):132-5. PubMed ID: 6363566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation in bullous skin diseases.
    Jordon RE
    J Invest Dermatol; 1975 Jul; 65(1):162-9. PubMed ID: 50385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation in pemphigus and bullous pemphigoid.
    Jordon RE
    J Invest Dermatol; 1976 Sep; 67(3):366-71. PubMed ID: 787432
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral cicatricial pemphigoid. (Immunofluorescent studies).
    Bean SF
    Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1977; 84(3 Pt 2):ORL530-3. PubMed ID: 329530
    [No Abstract]   [Full Text] [Related]  

  • 13. The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids.
    Jordon RE; Day NK; Sams WM; Good RA
    J Clin Invest; 1973 May; 52(5):1207-14. PubMed ID: 4573354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blister fluid for the diagnosis of subepidermal immunobullous diseases: a comparative study of basement membrane zone autoantibodies detected in blister fluid and serum.
    Zhou S; Wakelin SH; Allen J; Wojnarowska F
    Br J Dermatol; 1998 Jul; 139(1):27-32. PubMed ID: 9764145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid.
    Dainichi T; Chow Z; Kabashima K
    J Dermatol Sci; 2017 Dec; 88(3):265-270. PubMed ID: 28747266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid.
    Grando SA; Glukhenky BT; Drannik GN; Epshtein EV; Kostromin AP; Korostash TA
    Arch Dermatol; 1989 Jul; 125(7):925-30. PubMed ID: 2662908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of basement membrane zone antigens and C3 fragments in the blister fluid of bullous pemphigoid.
    Lohrisch I; Herrmann K; Haustein UF
    Br J Dermatol; 1980 Feb; 102(2):135-43. PubMed ID: 6992829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathology of bullous pemphigoid. Basement membrane deposition of IgE, alternate pathway components and fibrin.
    Provost TT; Tomasi TB
    Clin Exp Immunol; 1974 Oct; 18(2):193-200. PubMed ID: 4619597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of bullous pemphigoid and systemic lupus erythematosus.
    Kumar V; Binder WL; Schotland E; Beutner EH; Chorzelski TP
    Arch Dermatol; 1978 Aug; 114(8):1187-90. PubMed ID: 354534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte chemotaxis to the dermal-epidermal junction of human skin mediated by pemphigoid antibody and complement: mechanism of cell attachment in the in vitro leukocyte attachment method.
    Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo J
    J Invest Dermatol; 1981 Jun; 76(6):514-22. PubMed ID: 7017015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.